We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

STANDARD DIAGNOSTICS INC.

Standard Diagnostics develops rapid diagnostic tests that make it possible to diagnose various diseases at an earlier... read more Featured Products: More products

Download Mobile App




Accuracy of Malaria Tests Evaluated for Febrile Children

By LabMedica International staff writers
Posted on 01 Aug 2017
It remains challenging to distinguish malaria from other fever causing infections, as a positive rapid diagnostic test does not always signify a true active malaria infection. More...
Antigen persistence could increase the rate of false positive test results, leading to a wrong diagnosis in settings where other diagnostic tools are unavailable.

The phenomenon of false positive results after successful treatment can result in an overestimation of malaria positive cases and lead to misdiagnosis of the true cause of fever in children. Recent studies have reported a decreasing specificity and positive predictive value of specific rapid diagnostic tests (RDT) up to three to four weeks after successful malaria treatment.

Scientists at the Clinical Research Unit of Nanoro (Ouaga, Burkina Faso) and their colleagues conducted a prospective etiology study 2015 among febrile children less than five years of age in Burkina Faso. To assess bacterial and viral infection status blood, urine and stool samples were analyzed. The malaria Rapid Diagnostic Test (RDT) used was the SD Ag Bioline Pf that detects Plasmodium falciparum histidine-rich protein-2 (PfHRP2) and this test was performed by trained study nurses at the health facilities or the district hospital. Malaria diagnosis by microscopy was performed by expert laboratory technicians. Venous blood was collected into a pediatric blood culture bottle and incubated in a BACTEC 9050 instrument. Urine culture was done when a urine sample was positive for leucocytes and nitrite as indicated by a urine dipstick. Stool samples were specifically analyzed for group A rotavirus using one step rotavirus and adenovirus serotype 40/41 in a human feces test.

The investigators analyzed a total 683 blood samples with microscopy and RDT-PfHRP2. P. falciparum malaria was diagnosed in 49.8% (340/683) by microscopy compared to 69.5% (475/683) by RDT-PfHRP2. The RDT-PfHRP2 reported 29.7% (141/475) false positive results and 1.8% (6/340) false negative cases. The RDT-PfHRP2 had a high sensitivity (98.2%) and negative predictive value (97.1%), but a low specificity (58.9%) and positive predictive value (70.3%). Almost 50% of the alternative causes of fever were diagnosed by laboratory testing in the RDT false positive malaria group. The most common other causes of fever were bacterial bloodstream infection (16.3%), followed by rotavirus and adenovirus infections (6.4%) and urinary tract infection (4.3%).

The authors concluded that RDTs based on PfHRP2 have a good sensitivity and negative predictive value, but their use in malaria endemic areas may result in missing true causes of fever mainly in the malaria false positive group. They recommend the use of a second malaria RDT based on a different target, such as pLDH and/or using other simple diagnostic tests like urine and feces dipstick. The study was published on July 20, 2017, in the Malaria Journal.


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.